세포주 개발 혈청 시장은 2019년 9억 1,558만 달러에서 2027년 14억 6,792만 달러로 성장할 것으로 예상된다. 2020년부터 2027년까지 연평균 성장률(CAGR) 6.1%로 성장할 것으로 추정된다.
재생 의학은 장기뿐만 아니라 조직을 대체하거나 치료하고 선천적 결함을 정상화할 수 있는 잠재력을 가지고 있습니다. 특정 연령 관련 이상, 질병 및 외상은 조직과 기관을 손상시킵니다. 지난 10년 동안 조직 공학 산업은 눈부시게 발전했으며 이제는 생물학적 기능의 유지, 복구, 대체 및 향상을 위한 임상 치료법 개발에 초점을 맞춘 재생 의학의 더 넓은 영역으로 발전했습니다. , 세포 공학을 사용하여. 세포주 개발은 재생 의학에서 중요하고 변하지 않는 부분입니다. 따라서 재생의학의 발전으로 인해 세포주 개발에 사용되는 혈청에 대한 수요가 증가하고 있습니다.
세포주는 약물 테스트 및 개발, 세포주 개발에 중요한 역할을 합니다. 기반 치료법, 암 조직과 관련된 연구 등이 포함됩니다. 제약회사에서 개발된 신약은 분화된 줄기세포를 대상으로 안전하고 효과적으로 테스트하여 그 잠재력을 확인합니다. 또한, 세포 기반 모델을 사용하는 재생 의약품은 퇴행성 질환 및 외상성 부상에 대한 조기 개입 치료에 있어 연구자를 도울 수 있는 잠재력을 가지고 있습니다. 따라서 재생 의약품 사용의 급증은 세포주 개발 혈청 시장을 촉진합니다.
세포주 개발 혈청의 유리한 지역 시장
< br />
시장 통찰력
재생 의학 채택 증가
재생 의학은 조직을 대체하거나 치료할 수 있는 잠재력을 가지고 있습니다. , 장기뿐만 아니라 선천적 결함을 정상화합니다. 특정 연령 관련 이상, 질병 및 외상은 조직과 기관을 손상시킵니다. 지난 10년 동안 조직 공학 산업은 눈부시게 발전했으며 이제는 생물학적 기능의 유지, 복구, 대체 및 향상을 위한 임상 치료법 개발에 초점을 맞춘 재생 의학의 더 넓은 영역으로 발전했습니다. , 세포 공학을 사용하여. 세포주 개발은 재생 의학에서 중요하고 변하지 않는 부분입니다. 따라서 재생 의학의 발전으로 인해 세포주 개발에 사용되는 혈청에 대한 수요가 증가하고 있습니다.
세포주는 약물 테스트 및 개발, 세포 기반 치료법 개발, 관련 연구에 중요한 역할을 합니다. 다른 응용 분야 중에서 암 조직에 적용됩니다. 제약회사에서 개발된 신약은 분화된 줄기세포를 대상으로 안전하고 효과적으로 테스트하여 그 잠재력을 확인합니다. 또한, 세포 기반 모델을 사용하는 재생 의약품은 퇴행성 질환 및 외상성 부상에 대한 조기 개입 치료에 있어 연구자를 도울 수 있는 잠재력을 가지고 있습니다. 따라서 재생의료 사용의 급증은 세포주 개발 혈청 시장을 촉진합니다.
유형 통찰력
유형에 따라, 세포주 개발 혈청 시장은 소 태아 혈청, 성체 소 혈청, 돼지 혈청, 말 혈청 및 기타 동물 혈청으로 분류됩니다. 2019년에는 소 태아 혈청 부문이 시장에서 가장 큰 점유율을 차지했습니다. 이 부문의 성장은 혈액 검사, 소변 검사 및 다양한 영상 절차의 증가에 기인합니다.
유형별 글로벌 세포주 개발 혈청 시장– 2019년 및 2027년
최종 사용자 통찰력
적용을 기반으로 글로벌 세포주 개발 혈청 시장은 조직 공학 및 재생 의약품, 독성 테스트, 연구, 신약 발견, 생물 생산으로 분류됩니다. 2019년에는 생물생산 부문이 시장에서 가장 큰 점유율을 차지했습니다. 반면 신약 발견 부문은 예측 기간 동안 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다.
전략적 통찰력
제품 출시 및 승인 증가하는 소비자 수요를 충족하기 위해 기업이 글로벌 입지와 제품 포트폴리오를 확장하기 위해 일반적으로 채택하는 전략입니다. 세포주 개발 혈청 시장 참가자들은 전 세계적으로 고객 기반을 확대하기 위해 협력 전략을 채택하고 있으며 이를 통해 전 세계적으로 브랜드 이름을 유지할 수도 있습니다.
세포주 개발 혈청 시장 – 유형별
- 소 태아 혈청
- 성체 소 혈청
- 돼지 혈청
- 말 혈청
- 기타 동물 혈청
세포주 개발 혈청 시장 – 응용분야별
- 생물생산
- 약물 발견
- 조직 공학 및 재생 의학
- 독성 테스트
- 학술 연구
세포주 개발 혈청 시장 – 지역별
- 북미
- 미국
- 캐나다
- 멕시코
< li>유럽 - 프랑스
- 독일
- 이탈리아
- 영국
- 스페인
- 나머지 유럽
- 아시아 태평양(APAC)
- 중국
- 인도
- 대한민국
- 일본
- 호주
- 아시아 태평양 지역
- 중동 및amp; 아프리카(MEA)
- 남아프리카공화국
- 사우디아라비아
- UAE
- 중동 및 기타 지역 아프리카
- 남미 및 중앙아메리카
- 브라질
- 아르헨티나
- 남아메리카 나머지 지역
회사 프로필
- Lonza
- Thermo Fisher Scientific Inc.< /li>
- Sigma-Aldrich Corporation(Merck KGaA)
- (Cytiva) Danaher
- PAN Biotech
- Corning Incorporated
- 유럽 세포 배양 컬렉션(ECACC)
- Bovogen Biologicals Pty Ltd.
- WuXi AppTec
- ATCC(American Type Culture Collection) 그룹
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The cell line is established cell culture, wherein the cells multiply in the apt growth medium and space for growth. Different cell lines are made from other cells. The cell line development market growth is mainly attributed to the serum is broadly important as a source of growth and adhesion factors, lipids, hormones, and minerals for cells' culture in basal media. Besides, the serum also regulates cell membrane permeability and serves as a carrier for lipids, enzymes, micronutrients, and trace elements into the cell.
Increasing Adoption of Regenerative Medicines s expected to propel the growth of the Cell Line Development Serum market. Moreover, rising R&D investments and collaborations among by pharmaceutical and biotechnology companies.
The price of Cell Line Development Serum treatment is $ 168.80 for for fetal bovine serum and HyClone Cosmic Calf Serum, New Zealand origin cost at $ 256.00 USD. However, the cost profoundly differs based upon the customization
The List of Companies - Cell Line Development Serum Market
- Lonza
- Thermo Fisher Scientific Inc.,
- Sigma-Aldrich Corporation (MERCK KGaA)
- Cytiva (Danaher)
- PAN Biotech
- Corning Incorporated
- European Collection of Cell Cultures (ECACC)
- Bovogen Biologicals Pty Ltd.
- WuXi AppTec
- American Type Culture Collection (ATCC)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Nov 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Nov 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Nov 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Nov 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Nov 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)